Cargando…

P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors

[Image: see text] Protein p53 is degraded by the 26S proteasome, a protein complex that breaks down cellular proteins. Degradation begins with activation of the protein ubiquitin (Ub) by the ubiquitin-activating E1 enzymes, ubiquitin-conjugating E2 enzymes, and ubiquitin E3 ligases, linking Ub or th...

Descripción completa

Detalles Bibliográficos
Autores principales: do Patrocinio, Andressa Barban, Rodrigues, Vanderlei, Guidi Magalhães, Lizandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829948/
https://www.ncbi.nlm.nih.gov/pubmed/35155881
http://dx.doi.org/10.1021/acsomega.1c04726
Descripción
Sumario:[Image: see text] Protein p53 is degraded by the 26S proteasome, a protein complex that breaks down cellular proteins. Degradation begins with activation of the protein ubiquitin (Ub) by the ubiquitin-activating E1 enzymes, ubiquitin-conjugating E2 enzymes, and ubiquitin E3 ligases, linking Ub or the polyubiquitin chain to p53 and marking it for degradation by the 26S proteasome. E3 ubiquitin ligases participate in this process and regulate p53 stability. There are compounds that inhibit the 26S proteasome and interfere at the p53 level, and some of these inhibitors are used to treat cancer and other diseases and can stabilize tumor suppressor proteins through the p53 pathway. This review discusses how the ubiquitin–proteasome system, p53, and these compounds are related.